Positive topline results were announced from the second pivotal phase 3 study evaluating daridorexant (Idorsia), an investigational dual orexin receptor antagonist, for the treatment of insomnia.
Patients with COVID-19 appear to have a heightened risk for acute ischemic stroke compared with patients with influenza.
Heightened cognitive arousal at bedtime is linked to objective sleep disturbances and indicators of psychological hyperarousal at night and during the day.
Cognitively normal women have increased Alzheimer disease endophenotype, with higher β-amyloid deposition, lower glucose metabolism, and lower gray and white matter volumes.
The researchers concluded that effective monitoring of psychiatric and cognitive comorbidities was essential for patients with MS and updated treatment options applicable to the conditions of the viral pandemic are a necessity.
Rhythmic movement disorder is a rare motor disorder that results in frequent night sleep disturbances.
Researchers sought to identify and characterize stroke in COVID-19 in a single healthcare system in New York.
Healthcare professionals see the benefits of prescribing cannabis therapies but report significant knowledge gaps in both recreational and medical cannabis.
Naoto Kuroda, MD, of Wayne State University, in Detroit, Michigan, provided a checklist for clinicians about what they should ask and look out for in a telemedicine session with patients with epilepsy.
Approximately one-third of patients with migraine reported using opioids to treat their symptoms, a practice that contrasts with current guidelines.
